| |
| |
|
| Insider
Information: |
Fletcher R John |
| Relationship: |
Director |
| City: |
Beverly |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
443,308 |
|
|
Indirect Shares
|
617,551 |
|
|
| Direct
Value |
$1,077,654 |
|
|
|
Indirect Value
|
$1,176 |
|
|
| Total
Shares |
1,060,859 |
|
|
| Total
Value |
$1,078,830 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
2.0
|
| Percentage
Gain/Loss : |
 -44.6%
|
 98.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axcelis Technologies Inc |
ACLS |
Director |
2021-02-17 |
1,354 |
2003-12-17 |
0 |
Premium* |
|
|
NMT Medical Inc |
NMTI |
Director |
2004-12-14 |
151,756 |
2004-12-14 |
83,344 |
Premium* |
|
|
Panacos Pharma Inc |
PANC |
Director |
|
0 |
2005-09-15 |
528,147 |
Premium* |
|
|
Spectranetics Corp |
SPNC |
Director |
2017-08-09 |
0 |
2005-04-29 |
0 |
Premium* |
|
|
ClearPoint Neuro, Inc |
CLPT |
Director |
2024-05-14 |
91,950 |
2018-03-30 |
0 |
Premium* |
|
|
Repro Medical Systems Inc |
REPR |
Chairman of the Board,... |
2024-03-31 |
174,353 |
2019-06-14 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2023-01-17 |
23,895 |
2023-01-17 |
6,060 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REPR |
Repro Medical Systems Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$3.95 |
$6,249 |
D/D |
1,582 |
18,942 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-11 |
4 |
OE |
$6.40 |
$159,600 |
D/D |
22,500 |
74,604 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-11 |
4 |
S |
$22.96 |
$516,600 |
D/D |
(22,500) |
52,104 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-12 |
4 |
S |
$23.52 |
$470,400 |
D/D |
(20,000) |
52,104 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-12 |
4 |
OE |
$6.40 |
$136,000 |
D/D |
20,000 |
72,104 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2019-12-31 |
4 |
A |
$4.96 |
$12,127 |
D/D |
2,445 |
36,657 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2019-12-31 |
4 |
A |
$6.53 |
$12,498 |
D/D |
1,914 |
20,856 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2019-12-31 |
4/A |
A |
$6.53 |
$18,748 |
D/D |
2,871 |
21,813 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-03-31 |
4 |
A |
$7.50 |
$18,750 |
D/D |
2,500 |
24,313 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2020-03-31 |
4 |
A |
$3.57 |
$12,124 |
D/D |
3,396 |
40,053 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,881 |
58,985 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2020-05-28 |
4 |
S |
$26.52 |
$1,345,890 |
D/D |
(50,750) |
8,235 |
0 |
% |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-06-30 |
4 |
A |
$8.98 |
$18,750 |
D/D |
2,088 |
26,401 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2020-06-30 |
4 |
A |
$3.55 |
$12,109 |
D/D |
3,411 |
43,464 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2020-09-30 |
4 |
A |
$5.71 |
$12,128 |
D/D |
2,124 |
45,588 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-09-30 |
4 |
A |
$7.22 |
$18,750 |
D/D |
2,597 |
28,998 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-11-30 |
4 |
B |
$4.48 |
$94,313 |
D/D |
21,052 |
50,050 |
2.39 |
% |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-12-01 |
4 |
B |
$4.53 |
$5,776 |
D/D |
1,275 |
51,325 |
2.39 |
% |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2021-02-17 |
4 |
S |
$39.00 |
$268,359 |
D/D |
(6,881) |
1,354 |
0 |
% |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2021-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,676 |
8,676 |
0 |
- |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2021-03-31 |
4 |
A |
$19.57 |
$14,443 |
D/D |
738 |
47,134 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2021-05-17 |
4 |
B |
$4.30 |
$107,500 |
D/D |
25,000 |
82,990 |
2.39 |
% |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2021-05-21 |
4 |
B |
$3.33 |
$49,949 |
I/I |
15,000 |
15,000 |
2.1 |
% |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2021-05-24 |
4 |
B |
$3.39 |
$51,835 |
I/I |
15,300 |
30,300 |
2.1 |
% |
|
| CLPT |
ClearPoint Neuro, Inc |
Director |
– • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,003 |
50,137 |
0 |
- |
|
107 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
